Ligand-Based Design of a Potent and Selective Inhibitor of Cytochrome P450 2C19
作者:Robert S. Foti、Dan A. Rock、Xiaogang Han、Robert A. Flowers、Larry C. Wienkers、Jan L. Wahlstrom
DOI:10.1021/jm201346g
日期:2012.2.9
A series of omeprazole-based analogues was synthesized and assessed for inhibitory activity against CYP2C19. The data was used to build a CYP2C19 inhibition pharmacophore model for the series. The model was employed to design additional analogues with inhibitory potency against CYP2C19. Upon identifying inhibitors of CYP2C19, ligand-based design shifted to attenuating the rapid clearance observed for many of the inhibitors. While most analogues underwent metabolism on their aliphatic side chain, metabolite identification indicated that for analogues such as compound 30 which contain a heterocycle adjacent to the sulfur moiety, metabolism primarily occurred on the benzimidazole moiety. Compound 30 exhibited improved metabolic stability (Cl-int = 12.4 mL/min/nmol) and was selective in regard to inhibition of CYP2C19-catalyzed (S)-mephenytoin hydroxylation in human liver microsomes. Finally, representative compounds were docked into a homology model of CYP2C19 in an effort to understand the favorable inhibition or metabolism properties.
INHIBITORS OF H+K+ -ATPASE
申请人:Advanced Medicine, Inc.
公开号:EP1143991A2
公开(公告)日:2001-10-17
US4045564A
申请人:——
公开号:US4045564A
公开(公告)日:1977-08-30
[EN] INHIBITORS OF HK-ATPase<br/>[FR] INHIBITEURS DE HK-ATPASE
申请人:——
公开号:WO1999063940A2
公开(公告)日:1999-12-16
[EN] Disclosed are multibinding compounds which inhibit H<+>/K<+>-ATPase, an enzyme which is involved in the control of acid secretion in the stomach. The multibinding compounds of this invention containing from 2 to 10 ligands covalently attached to one or more linkers. Each ligand is an inhibitor of H<+>/K<+>-ATPase. The multibinding compounds of this invention are useful in the treatment gastroesophageal reflux disease ("GERD"). [FR] L'invention concerne des composés multiliaisons qui inhibent la H<+>/K<+>-ATPase, une enzyme qui intervient dans la régulation de la sécrétion d'acide dans l'estomac. Les composés multiliaisons de l'invention contiennent de 2 à 10 ligands fixés de manière covalente à un ou à plusieurs lieurs. Chaque ligand constitue un inhibiteur de H<+>/K<+>-ATPase. Les composés multiliaisons de l'invention sont utiles dans le traitement de reflux gastro-oesophagien pathologique (RGO).
Metal- and base-free regioselective thiolation of the methyl C(sp<sup>3</sup>)–H bond in 2-picoline <i>N</i>-oxides
A one-pot, two-stepsynthesis of pyridine-2-ylmethyl thioethers is developed through a TFAA-mediated [3,3]-sigmatropic rearrangement of pyridine N-oxides and TBAB-catalyzed direct conversion of trifluoroacetates into thioethers under metal- and base-free conditions. This methodology enables thiolation of the unactivated methyl C(sp3)–H bond in 2-picolines with thiols. Remarkable features of the method